Approval · Notice of Compliance 36560 · 2025
MYA: Notice of Compliance 36560
Issued December 16, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36560
- Date
- December 16, 2025
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to Product Monograph (to align with CRP approved PM)
- Canadian reference product
- YAZ (Bayer Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MYA | Not yet assigned | — |
Medicinal ingredients
- ETHINYL ESTRADIOL 0.02 MG per TAB
- DROSPIRENONE 3 MG per TAB